TMEM175 Activators

Chemical activators of TMEM175 utilize a variety of methods to enhance the channel's ability to conduct potassium ions across lysosomal membranes. ML335, for instance, directly targets TMEM175, stabilizing the channel in its open state and thereby facilitating the flow of K+ ions. Similarly, ML402 acts as a selective activator, binding to the channel and increasing its open probability. In a somewhat paradoxical fashion, Clofilium tosylate, a compound traditionally acknowledged as a potassium channel blocker, has been found to activate TMEM175 at certain concentrations by modifying the gating dynamics of the channel which, in turn, augments the K+ current. NS8593 hydrochloride contributes to the activity of TMEM175 by attaching to a site that is separate from the central pore, adjusting the channel's gating characteristics to favor an open state.

Further expanding the diversity of activation mechanisms, GW274150 indirectly stimulates TMEM175 by inhibiting inducible nitric oxide synthase, which leads to lower nitric oxide levels that could otherwise inhibit the channel. Dihydrokainic acid increases extracellular glutamate, leading to lysosomal membrane depolarization and consequent TMEM175 activation. Bithionol acts by modifying the lysosomal pH, which in turn affects the proton gradient crucial for TMEM175 regulation. Verapamil hydrochloride, although primarily associated with calcium channel modulation, can also activate TMEM175 by influencing the ionic balance within lysosomal compartments. Zinc pyrithione binds to modulatory sites on TMEM175, altering the gating kinetics and promoting channel opening. Harmane affects the redox state within lysosomes, inducing conformational changes in TMEM175 that favor an open state. Lastly, desipramine hydrochloride and flufenamic acid influence the lysosomal membrane and transmembrane electric field, respectively, each facilitating the open state of TMEM175 and enhancing potassium ion conduction.